H.R. 5269: RESULTS Act

Introduced Sep 10, 202595 cosponsors

Sponsor

Richard Hudson

Richard Hudson

Republican · NC-9

Bill Progress

IntroducedSep 10
Committee 
Pass House 
Pass Senate 
Signed 
Law 

Latest Action · Sep 10, 2025

1/4

Referred to Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. for review

Congress moves to cap Medicare's cuts to lab payments

5 min readLast updated May 19, 2026

Why it matters

Medicare's cap on annual lab-payment cuts — 15% a year — is set to expire after 2028, which would leave the rates labs depend on with no statutory floor. H.R. 5269 would make the cap permanent and tighten it to 5% starting in 2029, and rebuild how Medicare sets those rates using a private-claims database the bill says must hold at least 50 billion claims. It has drawn 76 bipartisan cosponsors and sits in the House Energy and Commerce and Ways and Means committees.

Medicare prices most clinical lab tests using a system built in 2014: labs report what private insurers pay them, and Medicare averages that into its own rate. The bill's sponsors argue the reporting has skewed toward large national labs, producing rates that don't reflect the broader market. H.R. 5269, the RESULTS Act, rebuilds the data source.

Starting with reporting periods on or after January 1, 2028, Medicare would stop relying on lab self-reporting for common tests and instead pull pricing from a national private-claims database run by an independent nonprofit. A test counts as "widely available" — and moves to the database — if more than 100 providers or suppliers were paid for it in the first half of the prior year.

The database has to be enormous. The bill requires at least 50 billion claims from more than 50 private payors and claims administrators, coverage of all 50 states and D.C., version control so only final paid amounts are used, and validation by an entity with no ties to government, insurers, or providers.

Before that, a transition: for reporting periods on or after January 1, 2027, labs would report payment for each test that received a final Medicare payment, and the reporting cycle stretches from every 3 years to every 4. HHS has until December 31, 2026, to write the rules.

There's a backstop. If HHS can't get the contract in place or the database has no usable data for a widely available test, Medicare would hold the prior year's rate and bump it by CPI-U inflation instead of cutting. Tests that aren't widely available and lack data get priced by comparison to a similar test or through a gapfilling process.

The bill also makes Medicare's cut limit permanent. Current law caps annual reductions at 15% through 2028 and then lets the limit lapse; H.R. 5269 replaces that with a 5% cap for 2029 and every year after. It adds public explanations of each rate and the data behind it, and reopens pricing decisions to administrative and court review for determinations on or after January 1, 2029.

H.R. 5269 Bill Summary

What H.R. 5269 actually does.

1

Routine lab tests get priced from a 50-billion-claim database

For widely available non-advanced tests, Medicare would set rates from a qualifying private-claims database starting with reporting periods on or after January 1, 2028, instead of relying only on labs reporting their own payments.

2

Medicare's cut limit becomes permanent at 5%

Current law caps annual payment reductions at 15% through 2028 and then ends the limit. The bill replaces that with a 5% cap for 2029 and every subsequent year.

3

A clear line for which tests count as "widely available"

A non-advanced lab test qualifies if more than 100 providers or suppliers were paid for it during the first 6 months of the year before the data collection period.

4

Missing data triggers an inflation bump, not a cut

If HHS can't secure the claims-data contract or the database lacks usable data for a widely available test, Medicare pays the prior year's rate increased by CPI-U inflation.

5

Medicare has to publish how it set each rate

The Secretary must release a public explanation of each payment rate, including the supporting data a lab would need to check the math.

6

Pricing decisions can be challenged again

The bill ends the bar on administrative and judicial review of these payment determinations for decisions made on or after January 1, 2029.

Who benefits from H.R. 5269?

Community, rural, and independent labs

These labs carry the most exposure if the 15% cut cap lapses after 2028. A permanent 5% cap and an inflation-based fallback give them a predictable floor instead of open-ended reductions.

Medicare patients who rely on routine bloodwork

When payment cuts push a local lab to stop offering a test, patients are the ones who lose access — most acutely in rural areas where there may be only one lab within reach.

The independent nonprofit that qualifies

An organization that already runs a large, validated private-payor claims database — and that has no ties to government, insurers, or providers — could win the federal data contract.

Researchers and labs auditing Medicare's math

Public rate explanations plus restored court review give outside parties a way to see, and contest, how each price was calculated starting in 2029.

Who is affected by H.R. 5269?

HHS and CMS

The agencies must write rules by December 31, 2026, certify a qualifying nonprofit, stand up a new data-collection process, and shift major lab tests onto claims-based pricing in 2028.

Labs that report payment data

Labs keep reporting under the current method through 2026, move to test-by-test reporting in 2027, then hand widely available tests over to the database in 2028.

Large national labs

The bill's sponsors argue the current system over-weights big labs' reported rates. Sourcing prices from a broad claims database instead changes whose payments drive Medicare's rates.

Private payors and claims administrators

Their claims data becomes the backbone of Medicare lab pricing, since the database must draw from more than 50 payors and administrators across every state.

Share this story
Tracking floor activity — no debate on H.R. 5269 yet. Updates when a legislator speaks on the record.

HR5269 Legislative Journey

1 actions

House: Committee Action

Sep 10, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

About the Sponsor

Richard Hudson

Richard Hudson

Republican, North Carolina's 9th congressional district · 13 years in Congress

Committees: Energy and Commerce

View full profile →

Cosponsors (95)

This bill gained 10 cosponsors in the last 30 days

This bill has 95 cosponsors: 46 Democrats, 49 Republicans, reflecting bipartisan support. Cosponsors represent 31 states: Alabama, Arizona, California, and 28 more.

46Democrats49Republicans·31 statesBipartisan

Committee Sponsors

24 Republicans across these committees haven't cosponsored yet. Mobilize their constituents

Constituent Resources

Get notified when this bill moves

Official Sources

H.R. 5269 on Congress.gov

The official Congress.gov page tracks the bill's text, sponsors, 76 cosponsors, committees, and status.

42 U.S.C. 1395m-1 (Social Security Act Section 1834A)

The entire bill amends section 1834A of the Social Security Act, codified at 42 U.S.C. 1395m-1, which governs Medicare clinical lab test payment reporting and rates.

CMS Clinical Laboratory Fee Schedule

CMS's page for the Medicare Clinical Laboratory Fee Schedule, the payment system the bill would revise.

CMS CLFS & PAMA Private Payor Data Reporting

The CMS resource for the private payor rate data reporting and timeline that the bill restructures by sourcing prices from a national claims database.

CMS Medicare Clinical Diagnostic Lab Tests Payment System Final Rule

CMS fact sheet on the rule that established the private payor-based payment methodology under section 1834A that this bill amends.

CMS Qualified Entity Program — Medicare Claims Data

The bill requires the claims-data nonprofit to be a certified qualified entity under section 1874(e); this CMS page describes that program.

42 CFR 414.502 — Clinical Laboratory Fee Schedule Definitions

The bill explicitly ties the post-2028 meaning of "applicable laboratory" to the definition in 42 CFR 414.502 as in effect on May 1, 2025.

H.R. 5269 Common Questions

What does H.R. 5269 do?

It changes how Medicare prices clinical lab tests. Common tests would be priced from a national private-claims database, a 5% cap on annual cuts becomes permanent in 2029, and an inflation-based rate kicks in when data is missing.

Has H.R. 5269 passed?

No. Rep. Richard Hudson introduced it and it was referred to the House Energy and Commerce and Ways and Means committees. With 76 bipartisan cosponsors it has broad support, but it hasn't moved out of committee.

Does H.R. 5269 stop Medicare from cutting lab payments?

It doesn't end cuts, it caps them. Today's 15% annual limit expires after 2028; the bill makes a limit permanent and lowers it to 5% a year starting in 2029, so rates can still fall, just not sharply.

When would the new Medicare lab rules take effect?

HHS must write rules by December 31, 2026. Test-by-test reporting starts with reporting periods on or after January 1, 2027, and the shift to the claims database starts on or after January 1, 2028. The reporting cycle moves from every 3 years to every 4.

What is a "widely available" lab test under H.R. 5269?

A non-advanced test that more than 100 providers or suppliers were paid for during the first 6 months of the year before the data collection period. Those tests get priced from the claims database; others use fallback methods.

Why does the database need 50 billion claims?

The bill requires at least 50 billion claims from more than 50 private payors, covering all 50 states and D.C. Sponsors say a database that large is needed for rates to reflect the national market rather than a narrow slice of labs.

What happens if the claims data isn't available?

For a widely available test, Medicare would hold the prior year's payment rate and increase it by CPI-U inflation if HHS can't secure the contract or the database has no usable data for that test.

Why is Congress changing how Medicare prices lab tests?

The bill's sponsors argue the 2014 reporting system skewed toward large national labs and produced rates that don't match the broader market, leading to cuts that hit smaller and rural labs hardest. H.R. 5269 is their fix.

Based on H.R. 5269 bill text

H.R. 5269 Bill Text

PDF

To amend title XVIII of the Social Security Act to provide long-term stability for Medicare beneficiary access to clinical diagnostic laboratory tests by improving the accuracy of, and feasibility of data collection for, the private payor-based fee schedule payment rates applied under the Medicare program for such tests, and for other purposes.

Source: U.S. Government Publishing Office

Bill Alerts

Get notified when H.R. 5269 moves

Committee votes, floor action, cosponsor changes — straight to your inbox.

Bill alerts + Legisletter's monthly briefing. Unsubscribe anytime.

Health Bills

9 related bills we're tracking

View all
H.R. 842

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Jodey Arrington
Jodey ArringtonR-TX
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+334
338 cosponsors

Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.

Oct 3, 2025

HouseHealth
H.R. 1262

Give Kids a Chance Act of 2025

Michael McCaul
Michael McCaulR-TX
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+309
313 cosponsors

Motion to reconsider laid on the table Agreed to without objection.

Dec 1, 2025

HouseHealth
H.R. 3514Surging+10

Improving Seniors’ Timely Access to Care Act of 2025

Mike Kelly
Mike KellyR-PA
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+292
296 cosponsors
+10 this month

Forwarded by Subcommittee to Full Committee by Voice Vote.

Jun 25, 2026

HouseHealth
H.R. 4206

CONNECT for Health Act of 2025

Mike Thompson
Mike ThompsonD-CA
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+234
238 cosponsors
+1 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jun 26, 2025

HouseHealth
H.R. 7973Gaining+6

Momnibus Act

Lauren Underwood
Lauren UnderwoodD-IL
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+208
212 cosponsors
+6 this month

Referred to the Subcommittee on Health.

Apr 20, 2026

HouseHealth
H.R. 999

Right to Contraception Act

Lizzie Fletcher
Lizzie FletcherD-TX
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+206
210 cosponsors
+4 this month

Referred to the House Committee on Energy and Commerce.

Feb 5, 2025

HouseHealth
H.R. 879

Medicare Patient Access and Practice Stabilization Act of 2025

Gregory Murphy
Gregory MurphyR-NC
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+191
195 cosponsors

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 31, 2025

HouseHealth
H.R. 3277Gaining+5

Ensuring Lasting Smiles Act

Neal Dunn
Neal DunnR-FL
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+162
166 cosponsors
+5 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 8, 2025

HouseHealth
H.R. 539

Chiropractic Medicare Coverage Modernization Act of 2025

W. Steube
W. SteubeR-FL
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+162
166 cosponsors
+4 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 16, 2025

HouseHealth

Tracking Health in Congress? Monitor bills, track cosponsor momentum, and launch advocacy campaigns — all from one advocacy platform.